460.76
Alnylam Pharmaceuticals Inc 주식(ALNY)의 최신 뉴스
Is Alnylam Pharmaceuticals Inc. stock cheap at current valuation2025 Bull vs Bear & Real-Time Volume Analysis - newser.com
Why Alnylam Pharmaceuticals Inc. (DUL) stock attracts wealthy investors2025 Price Action Summary & Verified Technical Signals - newser.com
How Alnylam Pharmaceuticals Inc. (DUL) stock reacts to fiscal policiesWeekly Trading Summary & Real-Time Volume Analysis - newser.com
Is Alnylam Pharmaceuticals Inc. stock a defensive play in 2025Trade Signal Summary & Fast Exit and Entry Trade Guides - newser.com
Regression analysis insights on Alnylam Pharmaceuticals Inc. performance2025 Top Gainers & Reliable Volume Spike Alerts - newser.com
Will Alnylam Pharmaceuticals Inc. continue its uptrendEarnings Miss & Smart Money Movement Tracker - newser.com
Will Alnylam Pharmaceuticals Inc. (DUL) stock sustain bullish trend into 2025Portfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Will Alnylam Pharmaceuticals Inc. stock deliver consistent dividends2025 Macro Impact & Short-Term High Return Strategies - newser.com
How risky is Alnylam Pharmaceuticals Inc. (DUL) stock compared to peers2025 Top Decliners & Expert Approved Trade Ideas - newser.com
Transcript : Alnylam Pharmaceuticals, Inc. Presents at Jefferies London Healthcare Conference 2025, Nov-19-2025 11 - MarketScreener
Is Alnylam Pharmaceuticals Inc. (DUL) stock a fit for income portfolios2025 Price Targets & Smart Swing Trading Techniques - newser.com
What data driven models say about Alnylam Pharmaceuticals Inc.’s futureVolume Spike & Fast Moving Stock Watchlists - newser.com
How to recover losses in Alnylam Pharmaceuticals Inc. stockPortfolio Update Report & Verified Momentum Stock Alerts - newser.com
Alnylam Pharmaceuticals Faces Weak Start with 6.56% Gap Down Amid Market Concerns - Markets Mojo
How institutional buying supports Alnylam Pharmaceuticals Inc. stockPortfolio Update Summary & Real-Time Volume Analysis - newser.com
Can Alnylam Pharmaceuticals Inc. (DUL) stock sustain institutional flowsJuly 2025 Sentiment & Safe Entry Point Alerts - newser.com
Hemophilia B Research Report 2025-2035: Market Led by UniQure, Pfizer, Novo Nordisk, HEMA Biologics, and Alnylam Pharmaceuticals as Next-Generation Therapies and R&D Investment Drive Innovation - Yahoo Finance
Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Alnylam Pharmaceuticals (ALNY): Assessing Valuation Following Positive HELIOS-B Data on Vutrisiran Efficacy - simplywall.st
Can Alnylam Pharmaceuticals Inc. (DUL) stock sustain revenue momentumJuly 2025 Sentiment & Smart Money Movement Alerts - newser.com
Alnylam, MongoDB, Quanta Services, 11 Others Join IBD Watchlists - Investor's Business Daily
자본화:
|
볼륨(24시간):